e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Resistance in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
M. B. N. B. Prasad, K. Shashirekha, R. K. Choudhary (New Delhi, Ranchi, India)
Source:
Annual Congress 2003 - Resistance in adults and children
Session:
Resistance in adults and children
Session type:
Thematic Poster Session
Number:
3265
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. B. N. B. Prasad, K. Shashirekha, R. K. Choudhary (New Delhi, Ranchi, India). Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre. Eur Respir J 2003; 22: Suppl. 45, 3265
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
Treatment results and follow up of patients with chronic multidrug resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR)
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009
The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
A study of prescription of second line drugs in chronic tuberculosis patients before confirmation of multi drug resistance bacteriologically
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
Development of multi-drug resistant tuberculosis among patients treated with category II regimen: A lung center of the Philippines experience
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
A study of role of rifabutin as an adjuvant in management of cases with multi-drug resistant pulmonary tuberculosis
Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Year: 2007
Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005
Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002
The relapses of tuberculosis with multiple drug resistance among patients treated under DOTS-Plus regimen
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Second and third line anti-tuberculosis drug's side effects during the treatment of patients with multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 555s
Year: 2003
Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
The efficacy of treatment of patients with drug resistant tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 661s
Year: 2007
Drug resistance pattern of directly observed treatment shortcourse (DOTS) category-II relapse patients
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009
Pattern of drug resistance and treatment outcome of pulmonary tuberculosis treated at a tertiary care tuberculosis center in India- A retrospective analysis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept